Direct Biologics gets FDA RMAT designation for EV drug to treat Covid-19
ExoFlo is an acellular human bone marrow mesenchymal stem cell (MSC) obtained EV product developed leveraging Direct Biologics’…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
13 Apr 22
ExoFlo is an acellular human bone marrow mesenchymal stem cell (MSC) obtained EV product developed leveraging Direct Biologics’…
13 Apr 22
Under the licensing deal, Juniper Biologics will develop and market the gene therapy to medical professionals and hospitals…
12 Apr 22
Under the partnership, ECM platform will be added to the capabilities of Takeda in gastroenterology research and development…
12 Apr 22
The monoclonal antibody will also be developed to treat several other conditions including ASCVD-related dyslipidemias: hypertriglyceridemia and hypercholesterolemia
11 Apr 22
The recalled vaccines form the lot were supplied in Norway, Poland, Portugal, Spain and Sweden from 13 to…
11 Apr 22
The vaccine will be produced by SII under the brand name Covovax and is authorised for active immunisation…
08 Apr 22
The proposed acquisition will boost Pfizer’s expertise in infectious disease research and development by providing a complementary approach…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
08 Apr 22
The EC approval is based on pivotal findings from the double-blind, randomised, placebo-controlled Phase III VOYAGE clinical trial…
07 Apr 22
The transaction will create a vertically integrated platform and cardiovascular disease franchise, which will support the discovery and…
07 Apr 22
The US FDA approval was based on positive results from EPIK-P1, a retrospective chart review study of Vijoice…